CJC-1295 without DAC / Mod GRF 1-29 10 MG
Original price was: $70.00.$50.00Current price is: $50.00.
CJC-1295 without DAC / Mod GRF 1-29 — short-acting GHRH analog for controlled research involving growth-hormone release, pituitary signaling, and GH/IGF-1-axis models.
CJC-1295 without DAC / Mod GRF 1-29 is a short-acting GHRH analog intended for controlled laboratory work. It is studied in experimental systems involving growth-hormone release, pituitary signaling, and GH/IGF-1-axis models. Descriptions of research pathways do not establish safety, effectiveness, or suitability for human or veterinary use.
Research areas include:
• GHRH-receptor and pituitary-response models
• Pulsatile growth-hormone signaling
• GH/IGF-1-axis biomarker studies
• Peptide stability and receptor-selectivity studies
Research limitations and safety:
• Published evidence and human safety data may be limited; composition, identity, purity, and experimental controls should be independently verified. Published or regulatory sources identify material safety uncertainties or adverse signals requiring particular caution.
• No dosing, administration, or therapeutic-use guidance is provided.
being sold for research only.
Reviews
There are no reviews yet.